OC 12 - Cancer associated thrombosis - Mechanisms

Moderator(s)

• 

  Cornelia Englisch, MD

  PhD Student
  Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna
  Vienna, Wien, Austria
• 

  Yohei Hisada, PhD

  Assistant Professor
  Medicine
  University of North Carolina at Chapel Hill
  Chapel Hill, North Carolina, United States

Presentations:

• 09:30 – 09:45 ICT

  Unraveling CD200R1 as a novel mechanism of thromboinflammation in cancer
  

  Presenting Author: Marisa A. Brake, PhD – Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School

  Co-Author: Dimitra Karagkouni – Beth Israel Deaconess Medical Center

  Co-Author: Rushad Patell, MBBS – Beth Israel Deaconess Medical Center

  Co-Author: Jacob G. Ludington – Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School

  Co-Author: Anna Falanga, MD PhD – University of Milano Bicocca, School of Medicine, Monza, Italy

  Co-Author: Marina Marchetti – Division of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII,Bergamo

  Co-Author: Laura Russo – Division of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy

  Co-Author: Simon Mantha – Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

  Co-Author: Marc Carrier, MD – Department of Medicine, University of Ottawa at the The Ottawa Hospital

  Co-Author: Phil S. Wells – University of Ottawa

  Co-Author: Donna Neuberg – Dana-Farber Cancer Institute

  Co-Author: Robert Flaumenhaft, MD, PhD – BIDMC/Harvard Medical School

  Co-Author: Ioannis Vlachos – Beth Israel Deaconess Medical Center

  Co-Author: Jeffrey I. Zwicker, MD – Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

  Co-Author: Sol Schulman, MD, PhD – Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School
• 09:45 – 10:00 ICT

  Activated FXI-antithrombin complex predicts venous thromboembolism (VTE) in a large prospective cohort of non-small cell lung cancer (NSCLC) patients
  

  Presenting Author: Patricia Gomez Rosas, MD – Hospital Papa Giovanni XXIII, Bergamo, Italy

  Co-Author: Marina Marchetti – Division of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII,Bergamo

  Co-Author: Magdolna Nagy – Department of Biochemistry, Maastricht University Medical Center+, Maastricht, The Netherlands

  Co-Author: Henri M.H Spronk, PhD – Maastricht University

  Co-Author: Cristina Verzeroli – Hospital Papa Giovanni XXIII, Bergamo, Italy

  Co-Author: Laura Russo – Division of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy

  Co-Author: Sara Gamba – Hospital Papa Giovanni XXIII, Bergamo, Italy

  Co-Author: Carmen Julia Tartari – Hospital Papa Giovanni XXIII, Bergamo, Italy

  Co-Author: Silvia Bolognini – Hospital Papa Giovanni XXIII, Bergamo, Italy

  Co-Author: Chiara Ticozzi – Division of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII,Bergamo

  Co-Author: Francesca Schieppati – Division of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy

  Co-Author: Andrea D'Alessio – Medical Oncology and Internal Medicine, Policlinico San Marco, Bergamo, Italy

  Co-Author: Roberto Labianca – Fondazione ARTET Onlus

  Co-Author: Hugo ten Cate, MD, PHD – Departments of Internal Medicine and Biochemistry, Maastricht University Medical Center+, Maastricht, The Netherlands

  Co-Author: Anna Falanga, MD PhD – University of Milano Bicocca, School of Medicine, Monza, Italy

  Co-Author: On behalf HYPERCAN study – HYPERCAN study
• 10:00 – 10:15 ICT

  MIR5683 predicts venous thromboembolism in advanced gastric cancer through regulation of thrombin generation, fibrinolysis and endothelial TFPI expression
  

  Presenting Author: David Zaragoza Huesca, Degree in Biology and Master – Department of Hematology and Medical Oncology, University General Hospital Morales Meseguer, Center of Hemodonation, University of Murcia, IMIB-Pascual Parrilla, 30003, Murcia, Spain

  Co-Author: Julia Peñas Martínez, PhD Student – Department of Hematology and Medical Oncology, University General Hospital Morales Meseguer, Center of Hemodonation, University of Murcia, IMIB-Pascual Parrilla, 30003, Murcia, Spain

  Co-Author: Raúl Teruel – REGIONAL CENTER OF HEMODONATION, DEPARTMENT OF HEMATOLOGY AND MEDICAL ONCOLOGY, UNIVERSITY GENERAL HOSPITAL MORALES MESEGUER, UNIVERSITY OF MURCIA, IMIB-PASCUAL PARRILLA, 30003, MURCIA, SPAIN.

  Co-Author: Guillermo Ricote – REGIONAL CENTER OF HEMODONATION, DEPARTMENT OF HEMATOLOGY AND MEDICAL ONCOLOGY, UNIVERSITY GENERAL HOSPITAL MORALES MESEGUER, UNIVERSITY OF MURCIA, IMIB-PASCUAL PARRILLA, 30003, MURCIA, SPAIN.

  Co-Author: Alberto Carmona Bayonas – REGIONAL CENTER OF HEMODONATION, DEPARTMENT OF HEMATOLOGY AND MEDICAL ONCOLOGY, UNIVERSITY GENERAL HOSPITAL MORALES MESEGUER, UNIVERSITY OF MURCIA, IMIB-PASCUAL PARRILLA, 30003, MURCIA, SPAIN.

  Co-Author: Ana Fernández Montes – Department of Medical Oncology, University-Hospital Complex of Ourense, 32005, Ourense, Spain

  Co-Author: Paula Jiménez Fonseca – Department of Medical Oncology, ISPA, Central University Hospital of Asturias, 33011, Oviedo, Spain

  Co-Author: Lola Macia Rivas – Department of Medical Oncology, ISPA, Central University Hospital of Asturias, 33011, Oviedo, Spain

  Co-Author: Patricia Morales del burgo – Department of Medical Oncology, ISPA, Central University Hospital of Asturias, 33011, Oviedo, Spain

  Co-Author: Laura Visa – Department of Medical Oncology, Hospital del Mar, 08003, Barcelona, Spain

  Co-Author: Raquel Hernández – Department of Medical Oncology, University Hospital of Canarias, 38320, Santa Cruz de Tenerife, Spain

  Co-Author: Eva Martínez de Castro – Department of Medical Oncology, University Hospital Marqués de Valdecilla, 39008, Santander, Spain

  Co-Author: Andrea Pereira Elorrieta – Department of Medical Oncology, University Hospital Marqués de Valdecilla, 39008, Santander, Spain

  Co-Author: María Eugenia de la Morena-Barrio, PhD – Servicio de Hematología, Hospital General Universitario Morales Messeguer, Centro Regional de Hemodonación, Universidad de Murcia, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII

  Co-Author: Pedro Garrido-Rodríguez – Servicio de Hematología, Hospital General Universitario Morales Messeguer, Centro Regional de Hemodonación, Universidad de Murcia, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII

  Co-Author: María Luisa Lozano – Servicio de Hematología, Hospital General Universitario Morales Messeguer, Centro Regional de Hemodonación, Universidad de Murcia, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII

  Co-Author: Constantino Martínez – Department of Hematology and Medical Oncology, University General Hospital Morales Meseguer, Center of Hemodonation, University of Murcia, IMIB-Pascual Parrilla, 30003, Murcia, Spain

  Co-Author: Rocío González-Conejero – Department of Hematology and Medical Oncology, University General Hospital Morales Meseguer, Center of Hemodonation, University of Murcia, IMIB-Pascual Parrilla, 30003, Murcia, Spain

  Co-Author: Irene Martínez Martínez – Servicio de Hematología, Hospital General Universitario Morales Messeguer, Centro Regional de Hemodonación, Universidad de Murcia, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII
• 10:15 – 10:30 ICT

  Cancer-associated fibroblasts promote venous thrombosis by releasing podoplanin-positive extracellular vesicles.
  

  Presenting Author: Toshiaki Shirai, PhD – Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi

  Co-Author: Nagaharu Tsukiji, PhD – Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi

  Co-Author: Tomoyuki Sasaki – Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi

  Co-Author: Saori Oishi – Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi

  Co-Author: Ryohei Yokomori – Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi

  Co-Author: Katsuhiro Takano – Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi

  Co-Author: Katsue Inoue – Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi
• 10:30 – 10:45 ICT

  Canonical and Non-Canonical FXII Functions Synergistically Drive Ovarian Cancer-Associated Thrombosis and Tumor Progression
  

  Presenting Author: Dillon Bohinc – Case Western Reserve University

  Co-Author: Kara Bane – Case Western Reserve University

  Co-Author: Jessica McAnulty – Universite of Michigan, School of Medicine

  Co-Author: Agharnan Gandhi – Universite of Michigan, School of Medicine

  Co-Author: Analisa DiFeo – Universite of Michigan, School of Medicine

  Co-Author: Evi X. Stavrou, MD – Department of Medicine, Hematology and Oncology Division, Case Western Reserve University (CWRU) School of Medicine